AbbVie Inc. Files 8-K on Financial Operations
Ticker: ABBV · Form: 8-K · Filed: Apr 3, 2025 · CIK: 1551152
| Field | Detail |
|---|---|
| Company | Abbvie Inc. (ABBV) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, debt, operations
Related Tickers: ABBV
TL;DR
AbbVie dropped an 8-K on April 3rd detailing its financials and debt notes.
AI Summary
On April 3, 2025, AbbVie Inc. filed an 8-K report detailing its financial condition and results of operations. The filing includes information on various senior notes, such as the Sec0.750 Senior Notes Due 2027 and Sec2.125 Senior Notes due 2028, indicating ongoing financial activities and debt management.
Why It Matters
This filing provides insight into AbbVie's current financial standing and debt structure, which is crucial for investors assessing the company's stability and future prospects.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any immediate or significant risks.
Key Players & Entities
- AbbVie Inc. (company) — Registrant
- April 3, 2025 (date) — Date of earliest event reported
- Sec0.750 Senior Notes Due 2027 (dollar_amount) — Debt instrument
- Sec2.125 Senior Notes due 2028 (dollar_amount) — Debt instrument
FAQ
What is the primary purpose of this 8-K filing for AbbVie Inc.?
The primary purpose of this 8-K filing is to report on AbbVie Inc.'s results of operations and financial condition.
On what date was the earliest event reported in this filing?
The earliest event reported in this filing was on April 3, 2025.
What specific types of financial instruments are mentioned in relation to AbbVie Inc.'s filing?
The filing mentions various senior notes, including Sec0.750 Senior Notes Due 2027, Sec2.125 Senior Notes due 2028, Sec2625 Senior Notes Due 2028, Sec2125 Senior Notes Due 2029, and Sec1.250 Senior Notes due 2031.
In which state was AbbVie Inc. incorporated?
AbbVie Inc. was incorporated in Delaware.
What is AbbVie Inc.'s business address?
AbbVie Inc.'s business address is 1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL 60064.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding AbbVie Inc. (ABBV).